Lv53
1420 积分 2023-06-20 加入
Randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of the denosumab biosimilar MW031 in Chinese postmenopausal women with osteoporosis
4小时前
已完结
Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer
1天前
已完结
Progression-free survival: it is time for a new name
14天前
已完结
Comparison of the efficacy and safety of first-line treatments based on clinicopathological characteristics for patients with advanced epidermal growth factor receptor mutated non-small-cell lung cancer: A systematic review and network meta-analysis
15天前
已完结
Debate on first-line treatment strategies in advanced non-small cell lung cancer with EGFR mutation: An expert panel meeting by the Italian Association of Thoracic Oncology (AIOT)
16天前
已完结
A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer
17天前
已完结
P1.08C.01 Targeted Therapy or Chemotherapy as Neoadjuvant Treatment for Resectable Stage II-IIIB EGFRm Lung Adenocarcinoma: A Study Between Four Cohorts
20天前
已关闭
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
22天前
已完结
Patterns of Interstitial Lung Disease and Prognosis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
1个月前
已完结
Defining clinically important overall survival thresholds: lessons from quality of life
1个月前
已完结
皖公网安备34019202002308
